Research Solutions, Inc. (RSSS) Earnings Call Transcript
November 17, 2026
Earnings Call Speaker Segments
Thank you, Leslie, and good morning to all of you. It's a pleasure to welcome you to the Research Solutions earnings call for the first quarter of fiscal year 2027. Joining me on the call are Roy W. Olivier, our Chairman and Chief Executive Officer; Dave Kutil, our Chief Financial Officer; and Josh Nicholson, our Chief Strategy Officer. Yesterday afternoon, after the market had closed, the company put out a press release announcing the results for the first quarter of fiscal 2027. That release can be found on the company's website at researchsolutions.com. Before management delivers their prepared remarks, I want to remind you that certain statements made today are forward-looking and are being made under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those expressed or implied because of a variety of factors; for a more detailed discussion of the risks that could affect the company's future operating results and financial condition, we refer you to Research Solutions' recent filings with the SEC. Also on today's call, management will reference certain non-GAAP financial measures, which we believe offer useful information for investors. A reconciliation of these measures to GAAP measures appears in the earnings press release issued yesterday afternoon. Lastly, I want to remind everyone that this call is being recorded and will be made available for replay through a link on the company's website. I would now like to turn the call over to Roy W. Olivier. Roy?
Thanks, John. As we keep building out the next generation of AI-driven research tools, we're tracking a handful of important metrics to make sure we stay on course toward that goal. Publisher participation and customer adoption, in our view, are two of the crucial metrics, and Q1 brought encouraging progress, though it was offset by softness in our B2C and document delivery business. Churn isn't yet where we'd like it to be, but it did improve slightly in Q1. Our B2B AI-related sales rose 38% sequentially versus Q4 FY '26; and as we reported last week, we closed a $1 million ARR deal last week and still see quite a few 5-figure, 6-figure and even some 7-figure opportunities in our pipeline; the pipeline is stronger than it has ever been; right now it stands at well over $5 million in ARR. To my mind, these early indicators confirm we're headed in the right direction. We launched an MCP for Copilot, supporting both Scite and Article Galaxy functionality. A researcher can interact with any supported LLM and then we ask that — and then ask that LLM to go fetch those documents. And Article Galaxy will retrieve them in a way that's copyright compliant. Adoption and interest in the Claude Enterprise and ChatGPT solutions we released earlier remain strong. As we noted in our release, gross margins continue to expand nicely even with lower revenue. Our excluding — sorry, after excluding onetime events, mainly severance and legal costs, adjusted EBITDA came to roughly $1.5 million. Operating cash flow was $1.2 million, and our balance sheet remains strong, with $12.6 million in cash and no long-term debt. That leaves us well positioned to invest where we believe shareholder value will grow the most. I'll turn the call over to Dave to walk through our fiscal first quarter financial results in more detail, and then I'll return with some comments and an outlook for the year ahead. Dave?
Thank you, Roy, and good morning to all of you. I'll begin by walking through the first quarter results, and after that I'll discuss cash flow along with the balance sheet. For the first quarter of fiscal 2027, total revenue came in at $11.9 million, versus $12.3 million during the first quarter of fiscal 2026. A rise in platform revenue was more than offset by transaction revenue declining. Platform subscription revenue for us rose 3.7%, reaching $5.3 million, compared with $5.1 million in the prior year quarter. That growth came from an increase in B2B platform ARR, driven by a combination of new logo generation plus upsells and cross-sells into our existing customer base, and it was partly offset by a decline in B2C ARR. During the quarter we added 22 net new platform deployments, which brought total deployments to 1,298 by quarter end. We closed the quarter with annual recurring revenue of $22.5 million, up 5.7% year-over-year, which breaks down as roughly $16.5 million in B2B ARR and approximately $6 million in normalized ARR tied to sites B2C subscribers. Versus the year ago period, B2B ARR grew $1.7 million, or 11.5%. Net B2B ARR rose approximately $257,000 in the quarter, while normalized B2C ARR fell approximately $299,000. Within B2B ARR, AI-related ARR was approximately $1.1 million, up 38% from the end of fiscal 2026. How we define and use annual recurring revenue and other non-GAAP terms is laid out in yesterday afternoon's press release. Transaction revenue came to approximately $6.6 million in the first quarter, compared with $7.2 million in the prior year quarter, a decline of roughly 8%, mainly reflecting lower paid order volume. Total active customers for the quarter stood at 1,360, versus 1,326 in the same period a year ago, as growth in academic customers more than offset a decline in corporate customers. Consolidated gross margin was 53.6% in the first quarter, a 300 basis point improvement over the first quarter of fiscal 2026. That increase reflects the ongoing shift in revenue mix toward our higher-margin platform business, which now accounts for 44.6% of total revenue, together with higher transaction margins. Despite the lower revenue base, gross profit dollars grew 2.5% to $6.4 million. Gross margin in the platform business was 87%, compared with 88.1% in the prior year quarter, reflecting slightly higher hosting and technology costs. Our transactions business posted gross margin of 26.7%, versus 23.8% in the prior year quarter, a 280 basis point improvement. That gain was primarily attributable to improved margins on our copyright content, reflecting favorable publisher mix and pricing. Total operating expenses were $5.5 million in the quarter, compared with $5.3 million in the prior year quarter. Higher general and administrative expenses, primarily severance and legal costs, along with higher technology and product development spending, were partially offset by lower sales and marketing expense and a noncash recovery of stock-based compensation resulting from forfeitures. Other expense for the quarter was $56,000, compared with $191,000 in the prior year quarter, primarily reflecting lower cash accreted interest on the site earn-out liability. Just to remind everyone, by November 2 we had finished 6 of the 8 quarterly site earn-out payments. For the quarter, net income came in at $765,000, or $0.02 per diluted share, versus $749,000, or $0.02 per diluted share, in the same quarter a year earlier. Adjusted EBITDA was $1 million for the quarter, an 8.6% margin, compared with $1.5 million in the first quarter of last year. That decline comes from higher general and administrative costs and more technology investment, partly offset by higher gross profit and lower sales and marketing expenses. Now on cash flow. Cash flow from operations in the first quarter of the fiscal year was roughly $1.2 million, versus roughly $1.1 million in the prior year quarter, aided by the timing of vendor payments. Moving to our balance sheet. Cash and cash equivalents stood at $12.6 million as of September 30, 2026, basically flat versus June 30, 2026, even after we funded $1.2 million of cash site earn-out payments during the quarter. We had no outstanding borrowings under our $500,000 revolving line of credit, and we carry no long-term debt; with a strong cash position and no debt, our balance sheet gives us room to finish the remaining site earn-out payments in fiscal 2027 while continuing to invest in the business. I'll hand the call over to Josh now. Josh?
Thanks, Dave, and good morning, everyone. This quarter I'd like to walk through four topics: the pace at which AI usage is expanding, the way that growth is appearing in our customer contracts, how researchers along with their agents are beginning to purchase content from us via their AI assistance, and then the product effort underlying all of it. First, AI usage continues to climb rapidly. Since February, we've tracked each instance of an AI assistant such as Claude, ChatGPT or Copilot reading a research paper through us. On our September call, that figure stood at 16 million papers. As of today, it exceeds 33 million. It doubled in roughly two months; and, as Roy noted, we are now offered inside ChatGPT and Microsoft Copilot in addition to Claude. That means researchers can access our tools through whichever assistant their company happens to use. Second, AI is appearing in the contracts of our business customers. Dave provided the AI-related ARR number. Beneath that figure, 49 business customers now have AI access stipulated in their contracts, an increase from 42 last quarter. The majority are existing customers who add AI access at renewal or expansion; and when they do so, the contract usually becomes meaningfully larger; this quarter we also finalized the biggest site deal in our history, an expansion of an existing Article Galaxy contract. That reflects the thesis we held on day 1 when we brought site into Research Solutions; and many thanks to our sales team for the effort in getting it closed. Third, researchers are beginning to purchase through their AI assistant. There has been considerable discussion this earnings season regarding AI agents making purchases. A few weeks ago, Uber reported that AI agents booked roughly 500 orders, 500 food orders and 4 rides during Halloween week, out of over 300 million trips in orders. DoorDash reported that agents had placed several hundred orders altogether. The consumer world is still awaiting agent-driven buying to gain traction; in our world, researchers are already purchasing in this manner. In September, a researcher at a corporate customer can ask their AI assistant to obtain a paper, view the price, buy it, and then the order is placed on their company's account and delivered to the user with the copyright cleared. In October, researchers at more than 15 corporate customers, among them several Fortune 500 enterprises, completed hundreds of articles and writes orders via their AI assistants and agents, an increase from a few dozen a month over the summer. It remains a small portion of our total orders, yet it is growing quickly, and it represents genuine business purchasing on invoice through existing accounts; we believe research is among the first places where AI-assisted buying works, for a simple reason. About half of what these assistants want to read sits behind a paywall. When the assistant reaches that wall, it requires a compliant way to obtain the paper and < > (00:12:28). We possess the publisher agreements, the pricing and the rights accumulated over 20 years. Fourth, a new Scite Assistant and what else we shipped. The largest thing we launched on the Scite side is a brand-new edition of the AI research assistant we offer; it takes all the capabilities we developed for assistants such as Claude and ChatGPT and puts them inside our own product, with extra research-oriented features added on top. A researcher is now able to search the literature and read full papers, and also clinical trials, drug safety data, patents and grants, along with the open web and gray literature, and can upload personal files and work with them. Each answer rests on real cited sources, and it verifies that those citations exist and that papers haven't been retracted. It turned into the default for individual users in October and is being rolled out to all our institutional customers at present. We also provided enterprise administrators with a dashboard so they can view and manage how AI is used across their organization. Over on the Article Galaxy side, we made AI access available to every Article Galaxy customer, embedded ordering within the AI assistant, as I mentioned, simplified buying the rights to use an article with AI, and completely rebuilt our reference manager. We also integrated Scite into Article Galaxy so open access papers arrive automatically; for publishers, our AI reads reporting now reveals which of their journals AI assistants are pulling from and how frequently they've hit a paywall. That has shifted the nature of our conversations with them. Twelve months ago, publishers were asking whether they should allow AI anywhere near their content. Today they ask how they get paid when it is. We're in discussions with many of the publishers we've partnered with for 20 years regarding what comes next, and we're excited by the progress on that front. In summary, AI usage has doubled since the previous call, and more business customers are writing it into their contracts. Researchers are already purchasing articles via their AI assistants, and publishers are keen to collaborate with us on it. AI won't be our undoing. It's arriving through us. Roy, the floor is yours.
Thanks, Josh and Dave. Thanks to all of you for being here. To wrap up, I really have just three points. First, as Josh mentioned, AI reaches customers through us rather than bypassing us. Since our previous call, AI reads of research papers have doubled, now exceeding 33 million. AI access to contracts is now held by 49 million business customers, and our pipeline — sorry, 49 business customers have AI access to their contracts. And our pipeline stands at more than $5 million in ARR, which is stronger than at any other point in our history. Second, you can see it in the numbers. B2B ARR rose 11.5% to $16.5 million. Total ARR came in at $22.5 million, and gross profit increased 2.5%, or 300 basis points, to 53.6%, while platform reached 45% of revenue. Third, we are accomplishing this from a position of strength: $1.2 million of operating cash flow, $1.2 million paid toward the Scite earn-out, and still $12.6 million in cash at quarter end, with no long-term debt. We look forward to giving you further updates in February. With that, I'll hand it over to the operator for Q&A. Operator?
Perhaps, first of all, on the B2B side for me. I suppose it would help if you could sort of walk us through what gross bookings came to during the quarter compared with churn dollars? And whatever further remarks you might have about churn and what you, sort of, expect going forward would be useful on the B2B side.
Certainly. Dave, would you like to handle that?
Yes, absolutely. So new bookings came in at roughly $500,000, and if you look at our run rate over the past two quarters, it has been somewhat uneven. The third quarter we reported last year, the year-end quarter, was around $1.3 million; so as I mentioned, that unevenness has more or less carried on. That said, the deal we announced last week will land in the upcoming quarter. So we're expecting that one to be strong. On the churn side, we're now at a pretty good run rate, not precisely where we'd want it, but compared with roughly a year ago, when we ran that all hands on deck churn analysis and brought in Gainsight, we're down about 30% from that point; and looking at the last three quarters, the pattern has held fairly steady at approximately $300,000 of churn. Again, that's not where we'd like to be, but it's a very meaningful improvement since we chose to implement Gainsight and take all of those strategic actions.
Understood; and perhaps regarding that big deal you announced. Could you perhaps discuss what the term is on that, and how that build compares with some of the smaller Scite deals you have?
That deal runs 1 year, though there's meaningful upside as we get into year 2 and 3. And the terms match a standard agreement. I mean it's — I think, Dave, correct me if I'm wrong, platform upfront.
That's right.
All right, understood. Then I just had a question about the transaction side. Your active customers keep increasing. Revenue, clearly, is still a bit soft. But I suppose that means orders per customer are declining. Is that mostly Agentic AI sort of replacing the document purchases, or budgets? And perhaps what are you seeing when it comes to results leveling off in the transaction segment?
Yeah. We keep seeing roughly single-digit year-over-year decreases in document delivery. Much of that is really caused by customer churn, a few customers we churned out who are still, sort of, a headwind for us in year-over-year growth. But we're seeing some other softness too, and we're not 100% certain why. It could be Agentic AI. It could simply be a stage in the research cycle. We can observe it; yet when we ask customers about it, it's about why is yours specifically down? We don't truly get very specific answers regarding why they're down, since they just have research cycles and at times they're up and at times they're down. But Josh, you might have some extra color on that.
Yes. There isn't a great deal for me to add beyond what Roy covered. In my view, the product is being used better. Search activity is up, engagement is up. Access is expanding via tokens and subscriptions. And once again, I believe purchases are now occurring through this new agent-based mechanism at a higher rate than at any point previously. So I still regard a good portion of this as something like a hangover from losing one very large, massive account. Roy and I trade views a bit on whether there's a zero-click phenomenon or not. So that is definitely one possibility. Clicks across the web are fewer, and more broadly as well; so it certainly could be that. But I do think there's potential for Agentic consumption to grow and to become a meaningful line for DocDel, though it's still quite early days there.
First off, I'd like to ask about the guidance you gave on the prior call — has anything shifted materially, or do you still view it as your expectation for the year? It called for continued growth in corporate and academic B2B, B2C approximately flat versus a year ago, transactions declining by low single digits, which I believe you just touched on, plus better adjusted EBITDA and cash flows.
Dave, anything new on that front?
Yes, so on the B2B side, the timing of that big deal shifted a bit compared with when we last spoke at year-end. That will affect top line sales, clearly not ARR, but top line sales, and it will carry through to EBITDA. It is not a huge amount. And keep in mind, looking ahead, we intend to build on that. The MCP-related ARR we mentioned will keep growing. As for the B2C figure we described as flat, we expected the quarter to unfold roughly the way it did, and it came in right at our budgeted number. We are seeing an uptick there as this second quarter begins. It is persisting; we are right in the middle of the quarter. So there may perhaps be a bit of upside there, but we prefer to look at that conservatively, since we know it is very cyclical and the winter break can sometimes disrupt that momentum. Still, we are optimistic about what we are seeing there. On the EBITDA side and the expense side, nothing has really changed in terms of cost structure. What we are really pleased about is the flow-through we are seeing on the gross profit line. That has been a strong component we have discussed quarter after quarter, and you can really see it now with our gross margins at 53-plus percent, which is also flowing through to the bottom line. So given that there have been a few items on the cost side that are more nonrecurring in nature and not part of our cost base going forward, we are very optimistic about the future. But this quarter, obviously, was affected by the delay in the new booking there and then some nonrecurring spend as well. So for the full year, probably from an EBITDA perspective, it will be a little lower than when we last talked. But on a run rate basis, EBITDA will keep increasing and probably even above what we discussed on the last conference call.
Yes, that's genuinely useful. And turning to your sales force, I'd like to know how you feel about the changes made over roughly the past year? Perhaps you could also address how the various teams are performing — new logos compared with upsell and renewal — plus any other detail you're willing to share?
Yes. What I'd say is we keep seeing very strong pipeline activity and results from the corporate team; they're performing amazingly. The academic team is doing a good job; they have a new leader. We've brought in some new headcount there. As a result, their start has been a little slower than the corporate team's. On the renewal upsell team, I'd characterize their work on the upsell side as pretty good, but churn is still offsetting too much of it; so it's encouraging that we're seeing modest improvement in churn thanks to the investments in Gainsight we made 6, 9 months ago. And as I laid out on the last call, we reorganized that group and added more people to it so each rep handles fewer accounts, which we believe will pay off through better coverage and better customer communication in the quarters ahead. So as churn keeps improving, net ARR growth will keep growing quite substantially, because, as I mentioned, they do a good job on upsells; churn just remains, in my view, our biggest pain point.
All right, that’s clear. One final thing from me, and it’s about sales cycles. I wanted to ask whether you’re noticing any meaningful shift compared with where things have typically stood, given bigger deal sizes or the addition of the AI component?
Sorry, could you repeat the first part of your question? Which cycle was that?
Sales cycles.
Oh, right. Yeah, our — deals still tend to get closed by us pretty quickly. What I mean is, typically it's 2, 3 months. Quite a big share of what we closed during the quarter were actually deals that got generated in that same quarter; but the bigger deals are taking more time; so that $1 million deal we issued a press release about had been a heads down effort, with a lot of people working on it for a year. So in a lot of cases it really depends on deal size. We continue to do plenty of smaller deals, and those usually have fairly quick sales cycles. Now, getting into it — I had meant to bring this up earlier. I believe a $70,000 deal closed the day before yesterday, and last month we did one for $100,000, if I recall correctly. The $1 million deals, though, need more time. Usually it takes five, six, or seven months to move them through every approval stage — AI review, software tech, and IT reviews. So the smaller deals stay in that two-to-three-month window, while bigger ones take longer; the upside is that ASP rises, which was nice.
When you zero in on that big deal, you're asking how many comparable customers of similar scale — in terms of what they themselves do — exist within your user base, right? Sort of trying to gauge how repeatable that is over the long run, and whether this was a sizable existing client growing steadily, or whether there's a meaningful jump, perhaps from something like added AI functionality?
We don't view that as a one-off deal. Other large deals sit in our pipeline too — some in the 6 figures, some even in the 7 figures — and they look similar. The thing that motivates them is this: these large companies are struggling with how to connect their different silos. They have multiple content subscriptions. They have multiple pieces of content that they own. They may already have Article Galaxy installed, or something similar to Article Galaxy installed; and how do they make this research process more efficient and take steps out of it. Another deal in progress — a pharma company about the same size as the $1 million deal, also a 7-figure deal — involves us reducing the research steps by 11 steps. Apply that across thousands of researchers, and it does accelerate research and enhance the quality of the output. Our pricing reflects the value delivered, so this isn’t some one-off arrangement. The customer behind that $1 million deal has worked with us for years on the Article Galaxy side, though revenue there has likely been fairly flat for five years or longer. This marks a substantial increase, since we can significantly reduce both the steps involved and the time required for them to complete a research project. That’s essentially what we’ve aimed to create by serving as part of the infrastructure rather than as an occasional plug-in. Josh, if you’d like to add anything, please go ahead.
Yeah. Actually, I'd say it's quite repeatable. And there's another fairly interesting angle here, which is that it isn't simply about having AI features—it also matters who we're engaging with inside these organizations. AI budgets, I'd argue, are rising in both the corporate and academic worlds, while library budgets and content budgets have tended to stay flat or shrink over time. So when you bring new stakeholders into the discussion, the ones for whom these figures are more typical, closing that deal definitely becomes simpler. That said, I do believe there's a whole set of AG customers that are reasonably substantial and have been established for a while, and I see a major opportunity to grow them; and I think they're accustomed to these, right? For us this is a significant deal, but for many of these groups it's likely just a standard-sized license. So again, I think this ties back to the thesis from day 1: hey, we've got an innovative tool. We've got a terrific customer base. Let's go into that base and expand. And I think that comes from a combination of the AI, a combination of the product, but really it's also a big testament to the sales team believing and knowing that, hey, this isn't a one-off or an unusual deal. This is something we can repeat again and again if we're patient and follow the process; and as Roy mentioned, bring in a lot of different people, right? These deals do take somewhat longer. Product is deeply involved. There are more in-person visits, but all of it works out and is very much worth it. So I'm definitely enthusiastic about some of the other deals we have going in the pipeline too, because again, we don't want this to be merely a onetime PR. We want this to become the new norm going forward. And I think it truly does reflect the value we're delivering to these groups.
All right. When I look at transactions and gross margins, and I look back at last year, it kind of began around the 24% mark and finished at 26%. Right now you're just a bit below 27%. Could you discuss the underlying trends that are driving that improvement, and how sustainable or extensible that might be?
Yes, I can handle that question. We genuinely believe that a few of the actions we mentioned two quarters back are paying off — and again, not only — we discuss the platform transactions to platform transition a lot, and that remains probably the largest driving factor. But we also examined transactions pricing too. So we are seeing part of that effect. We're keeping, as we said we would, keeping our cost structure in place regarding cloud storage and AI costs too; so we're handling those quite well. And I believe a few of the savings projects, again, which we brought up three quarters ago, are beginning to pay off. So it's genuinely a combination of all those events and strategies that, in our view, make that margin fairly durable as we go forward.
One last thing from me. If you look at how the OpEx lines moved, R&D came up somewhat. There were some one-off items, I believe, that hit G&A, and sales and marketing declined. To what extent do you figure the 1Q run rates capture what lies ahead for us? Or is it possible to return to something closer to the posture we had in the fourth quarter?
I expect a little of it will carry into the second quarter. But as I mentioned earlier, over the long term it certainly won't be part of our run rate cost structure. So — and there are some items I didn't address, on the R&D technology side, that we're doing for security purposes, IT security projects that have roughly a 6-month life cycle here. Once we get those in place, those one-off project costs will disappear. And we believe that then underpins everything Josh and Roy discussed regarding these larger deals. They do require considerably more time, but they also strengthen some of the IT security we have; and alongside those actions, we'll feel we're in great shape; and then the final point I'd make, sales and marketing, we'll probably increase that somewhat. On earlier calls I've spoken about the spend level being something we can change week to week. And since we're emerging from that summer lull we anticipated, and we're seeing some returns early in the middle part of this quarter, we'll probably dial up the advertising spend a little; so that's the one area where I'd say we're actually somewhat lower in the first quarter of the fiscal year. And then going forward, we'll likely raise that by another $100,000 or $200,000; but on the whole, the net run rate ought to be lower once we work through these projects and one-off items.
Congrats on big guess deal.
Thanks.
So what's your take — it sounds as though there are more big deals in the pipeline. I was just curious, really, to get a sense of how likely or possible another deal around the $1 million mark is over the next 12 months or so.
I honestly wouldn't know how to estimate that. I'd say it's probable. Whether it's 60% or 90% I can't tell you; it — some deals are quite far along the longer sales path I described. And one in particular is looking very good. But in my experience with elephant-type deals, nothing is finished until it's finished, and there are 100 ways things can go sideways. So I wouldn't commit to it, but I think there's a good probability we close something. When you say end of the year, I'm assuming you mean fiscal year, not calendar.
Yes, absolutely. So then, could you speak a bit about the way this product works — does it actually let your customers spend less on tokens, or is it more about removing steps from the process?
Yes, Josh, token spend is something you can affect, but the process steps matter a great deal there, since when you have 3,000 to 4,000 researchers, and every one of them is a high-income person, cutting steps carries a substantial financial effect on your cost structure or on how efficient those researchers are. But Josh, would you like to address the token side of it?
Right. It doesn't really come down to token spend. In fact, for a lot of these cases, what they're consuming is their own tokens rather than ours in order to get this done. What I think it really comes down to is that they've got a handful of separate tools, and their researchers — and again, that could be hundreds or thousands of people — have to move back and forth among those tools, and then they have to run this process, frequently medical writing, thousands of times each year. So those steps that Roy described as 11 — if you truly break it down into every step, it's likely far more than that. As a result, the way they have to work is quite clunky, but they must do particular things in particular ways. So honestly, when Article Galaxy and Scite are used together, it makes for a strong one-two combination with AI to accomplish things that still comply with the regulatory steps that are required, while helping those humans reduce time and, in some cases, reduce even the human effort; so I think it's really more a matter of speeding up the time the humans need and streamlining those workflows, again, in a way that's compliant with copyright. If you have to verify the reuse rights for hundreds of different articles and you must do them one at a time, that's an enormous hassle and consumes a lot of time. And if you can accomplish that fully automatically or even just at a glance, that by itself represents a major gain in efficiency. So we observe that across many different steps; and again, these calls are quite enjoyable to be part of, because you're unraveling these large, complicated webs and delivering a genuinely good solution to these groups.
Yes, and that means reaching the customer where they actually are. I suppose, given how you've been able to grow organically, then innovate organically, and produce cash flow organically, why aren't you being aggressive about buying back shares?
Well, that's come up before. I believe everyone on the Board agrees strongly that certainly at the current share price, that's arguably the best use of cash. And as soon as we're able to announce something more definitive on that front, you'll see it; so it isn't something we're doing today, but we agree that's a very, very good use of cash.
Could you all speak a bit about how publishers are participating? And Josh, I believe in your prepared remarks you mentioned that your ties with publishers are becoming deeper since you're able to demonstrate more clearly which paper gets read, and which paper people might want access to but cannot get due to a paywall. How is that shifting the discussion with some of your publishers?
Yeah. So with both products, we truly aim to be more strategic alongside publishers; and as a result, we hold a great deal of highly valuable data. What gets purchased, what gets rented, what gets refused in AI, what gets utilized in AI. A new standard known as counter exists to establish, roughly, the ROI or worth of subscriptions; and in the past, that has meant how do humans read content, correct? How is it downloaded, how is it viewed, and so on. Counter, in the middle of October, released new reports examining Agentic usage. And so we are rather uniquely positioned to, sort of, demonstrate that demand; we have a public page displaying this broken down by publisher, broken down by journals, letting journals or publishers or societies obtain these metrics and then speak with us. And so that is a very active focus area for us, where we speak with publishers on a regular basis, attend more events, and then I would say, evolve our existing agreements with them; these agreements with publishers can essentially help publishers protect their subscription value in an AI world since we're supplying them the metrics. They can expand their subscription value once more because we're supplying them the metrics or — and I think this is, sort of, the intriguing area for some growth for both us and them, they can sell metered reads to their content into AI. And so there's a bunch of a few different start-ups also operating in this space. There are some hosting agencies such as Silverchair and Atypon also operating in this space; but I think our big differentiators are our corporate customer base, which is by far the largest among anyone offering any kind of similar functionality and the fact that we already have these established relationships of sending royalties to publishers. And so it's really a nice narrative and data that we can present to publishers and say, "Hey, we want to work with you strategically to help bring your content into AI." And I really do think how content is consumed is transformationally, sort of, shifting. If you look at print to web to AI, I think on average, people are reading perhaps 20 articles a month. And now if you look at it an AI, the AI is consuming 300 to 600 articles per month. What we're seeing is really a sharp jump in consumption, since AI is able to read an article right away, whereas a person would take hours to do it. That's a major element of our plan: bringing these publishers on board, making more of their content available alongside them, and then delivering strategic value to them through data and revenue so they engage with us deeply. So yes, there's quite a bit more in the pipeline. We issued one press release about MDPI, and hopefully more will follow soon, spotlighting the traction we're gaining there.
Great. All right. Plenty to consider there; and perhaps regarding that big transaction you closed only a few weeks back, how significant is your content and your access to publishers in that deal? And to what extent is it actually supplying the infrastructure needed to streamline their processes?
Yeah. So for that one, I'd say it's more the second thing. I think the infrastructure is really what's there. Of course, having solid full text search across all those publisher relationships matters a great deal. But had we lost 1 or 2 publishers there, I don't believe the deal would have changed at all. And so I think we discuss strategy a lot, and we're handing you these rather intricate meter greeds and all these various items. In this instance, I think it's fairly straightforward, right? There are big customers out there with simple challenges or perhaps not simple challenges, big challenges. And if we come in and use our long-standing relationship with them, we can demonstrate to them, "Hey, this is how you can solve that." And that's a combination of AI. It's a combination of our content relationships on both products. And then I think it's also a credit to the sales team, right? We have some folks who can really go and across and handle these enterprise deals rather than kind of checking down at a smaller 6-figure deals, right? It requires some patience; it's a multi-stakeholder on both sides, their product and ours and a lot of listening and again, kind of, going to where the user is. And so that, to me, is exciting because, again, we have plenty of very large customers. And in some cases, they're not paying the largest amount, right? And so that is an opportunity that I think we see.
Appreciate all of you being here on today's call. We're looking forward to talking with you in February about how we did in the second quarter of FY '27. Take care.
Thanks, everyone — that wraps up today's session. We're grateful you took the time to join us. You can go ahead and disconnect now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Research Solutions, Inc. transcript - plus 131,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Research Solutions, Inc. earnings transcripts and 131,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.